Author:
Kawai Satoshi,Fujii Takuma,Kukimoto Iwao,Yamada Hiroya,Yamamoto Naoki,Kuroda Makoto,Otani Sayaka,Ichikawa Ryoko,Nishio Eiji,Torii Yutaka,Iwata Aya
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int. J. Gynaecol. Obstet. 125, 97–98,
https://doi.org/10.1016/j.ijgo.2014.02.003
(2014).
2. International Agency for Research on Cancer, GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012,
http://globocan.iarc.fr/Default.aspx
(2012).
3. Maniar, K. P. & Wei, J. In The Global Library of Women’s Medicine (ed. Arulkumaran, S.) (The International Federation of Gynecology and Obstetrics, 2017).
4. Kiviat, N. B., Hawes, S. E. & Feng, Q. Screening for cervical cancer in the era of the HPV vaccine–the urgent need for both new screening guidelines and new biomarkers. J. Natl. Cancer Inst. 100, 290–291,
https://doi.org/10.1093/jnci/djn038
(2008).
5. Moriarty, A. T. & Wilbur, D. Those gland problems in cervical cytology: faith or fact? Observations from the Bethesda 2001 terminology conference. Diagn. Cytopathol. 28, 171–174,
https://doi.org/10.1002/dc.10278
(2003).
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献